Saketha Drugs And Intermediates Profile
Key Indicators
- Authorised Capital ₹ 1,840.00 Cr
as on 14-05-2024
- Paid Up Capital ₹ 1,828.95 Cr
as on 14-05-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2016
- Revenue %
(FY 2016)
- Profit 63.73%
(FY 2016)
- Ebitda 63.73%
(FY 2016)
- Net Worth -0.97%
(FY 2016)
- Total Assets 1.98%
(FY 2016)
About Saketha Drugs And Intermediates
- CIN/LLPIN
U24239TG1995PLC020625
- Company No.
020625
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jun 1995
- Date of AGM
26 May 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc-Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Saketha Drugs And Intermediates?
Board Members(0)
| Name | Designation | Appointment Date | Status |
|---|
Financial Performance of Saketha Drugs And Intermediates.
Saketha Drugs And Intermediates Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 63.73% increase in profit. The company's net worth dipped by a decrease of 0.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saketha Drugs And Intermediates?
In 2016, Saketha Drugs And Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saketha Drugs And Intermediates?
Unlock and access historical data on people associated with Saketha Drugs And Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saketha Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saketha Drugs And Intermediates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
